Pfizer Wields Ferring Win To Extend Combo Drug Exclusivity
The U.S. Food and Drug Administration should extend exclusivity for Pfizer Inc. combination drug Duavee in light of Ferring Pharmaceuticals' recent court win on exclusivity for a different combination drug, Pfizer...To view the full article, register now.
Already a subscriber? Click here to view full article